dipyridamole has been researched along with Diabetic Cardiomyopathies in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cognet, T | 1 |
| Vervueren, PL | 1 |
| Dercle, L | 1 |
| Bastié, D | 1 |
| Richaud, R | 1 |
| Berry, M | 1 |
| Marchal, P | 1 |
| Gautier, M | 1 |
| Fouilloux, A | 1 |
| Galinier, M | 1 |
| Carrié, D | 1 |
| Massabuau, P | 1 |
| Berry, I | 1 |
| Lairez, O | 1 |
1 other study available for dipyridamole and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value.
Topics: Aged; Aged, 80 and over; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Diabetes | 2013 |